Mirae Asset Global Investments Co., Ltd. Novo Nordisk A S Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Novo Nordisk A S stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 475,490 shares of NVO stock, worth $51.2 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
475,490
Previous 276,599
71.91%
Holding current value
$51.2 Million
Previous $39.5 Million
43.4%
% of portfolio
0.25%
Previous 0.2%
Shares
28 transactions
Others Institutions Holding NVO
# of Institutions
1,951Shares Held
320MCall Options Held
5.22MPut Options Held
5M-
Jennison Associates LLC20.2MShares$2.17 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.6MShares$1.57 Billion0.16% of portfolio
-
Bank Of America Corp Charlotte, NC14.2MShares$1.53 Billion0.18% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.4MShares$1.44 Billion0.83% of portfolio
-
Fayez Sarofim & CO Houston, TX12.6MShares$1.35 Billion4.91% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $243B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...